iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Acromegaly

Acromegaly

Diagnosis and management of excess growth hormone.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Endocrinology

Clinical Guidelines

A Consensus Statement on acromegaly therapeutic outcomes
Local
A Pituitary Society update to acromegaly management guidelines
Local
Acromegaly: An Endocrine Society Clinical Practice Guideline
Local
Acromegaly: Developing Drugs for Treatment (FDA Guidance)
Local
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly
Local
Consensus on criteria for acromegaly diagnosis and remission
Local
Diagnosis and Management of Acromegaly: A Consensus Statement of the Pituitary Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism
Local
Malaysian Consensus Statement for the Diagnosis and Management of Acromegaly
Local
NICE Clinical Guideline CSG10: Pasireotide for acromegaly as third line treatment in adults
Local

Recent iatroX Q&As

  • How do I interpret serum IGF-1 levels in the context of suspected acromegaly, and what are the next steps if levels are elevated?Updated: 8/16/2025
  • What are the recommended referral criteria for a patient with suspected acromegaly to an endocrinologist?Updated: 8/16/2025
  • How should I monitor a patient with acromegaly after treatment to assess for disease control and potential complications?Updated: 8/16/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play